Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Early body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer.

Op den Kamp CM, De Ruysscher DK, van den Heuvel M, Elferink M, Houben RM, Oberije CJ, Bootsma GP, Geraedts WH, Pitz CC, Langen RC, Wouters EF, Schols AM, Dingemans AM.

J Cachexia Sarcopenia Muscle. 2014 Jun;5(2):127-37. doi: 10.1007/s13539-013-0127-5. Epub 2014 Jan 23.

2.
3.
4.

Interfraction interval does not affect survival of patients with non-small cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy: a multivariate analysis of 1076 RTOG patients.

Werner-Wasik M, Scott C, Graham ML, Smith C, Byhardt RW, Roach M 3rd, Andras EJ.

Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):327-31.

PMID:
10760427
5.
6.

Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery.

Patel AB, Edelman MJ, Kwok Y, Krasna MJ, Suntharalingam M.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1106-12.

PMID:
15519781
7.

 ¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose.

Massaccesi M, Calcagni ML, Spitilli MG, Cocciolillo F, Pelligrò F, Bonomo L, Valentini V, Giordano A.

Radiat Oncol. 2012 Jul 10;7:106. doi: 10.1186/1748-717X-7-106.

8.
9.
10.

Toxicity of concurrent hyperfractionated radiation therapy and chemotherapy in locally advanced (stage III) non-small cell lung cancer (NSCLC): single institution experience in 600 patients.

Jeremić B, Miličić B, Milisavljevic S.

Clin Transl Oncol. 2012 Aug;14(8):613-8. doi: 10.1007/s12094-012-0848-5. Epub 2012 Jul 12.

PMID:
22855143
11.

Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database.

Werner-Wasik M, Paulus R, Curran WJ Jr, Byhardt R.

Clin Lung Cancer. 2011 Jul;12(4):245-51. doi: 10.1016/j.cllc.2011.03.026. Epub 2011 Apr 24.

PMID:
21726824
12.

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR.

J Natl Cancer Inst. 1996 Sep 4;88(17):1210-5.

13.

Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.

Frasci G, Comella P, Scoppa G, Guida C, Gravina A, Fiore F, Casaretti R, Daponte A, Parziale A, Comella G.

J Clin Oncol. 1997 Apr;15(4):1409-17.

PMID:
9193333
14.

Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy.

Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Lebesque J.

Radiother Oncol. 2005 May;75(2):157-64.

PMID:
15890421
15.

Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma.

Bradley J, Deasy JO, Bentzen S, El-Naqa I.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1106-13.

PMID:
15001251
16.

Dosimetric and clinical predictors of acute esophagitis in lung cancer patients in Turkey treated with radiotherapy.

Etiz D, Bayman E, Akcay M, Sahin B, Bal C.

Asian Pac J Cancer Prev. 2013;14(7):4223-8.

17.

Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.

Jiang ZQ, Yang K, Komaki R, Wei X, Tucker SL, Zhuang Y, Martel MK, Vedam S, Balter P, Zhu G, Gomez D, Lu C, Mohan R, Cox JD, Liao Z.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):332-9. doi: 10.1016/j.ijrobp.2011.06.1963. Epub 2011 Nov 11.

PMID:
22079735
18.
20.

Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.

Komaki R, Seiferheld W, Ettinger D, Lee JS, Movsas B, Sause W.

Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):548-57.

PMID:
12062596
Items per page

Supplemental Content

Write to the Help Desk